# TRAQinform Assessment of Immunotherapy Response

> **NCT05819255** · — · COMPLETED · sponsor: **AIQ Solutions** · enrollment: 26 (actual)

## Conditions studied

- Melanoma

## Interventions

- **OTHER:** Non-Interventional

## Key facts

- **NCT ID:** NCT05819255
- **Lead sponsor:** AIQ Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-23
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05819255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05819255, "TRAQinform Assessment of Immunotherapy Response". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05819255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*